Variable CD34(+) recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic

Donor registries and transplantation societies recommend cryopreservation of unrelated donor hemopoietic progenitor cell (HPC) products before the recipient commences conditioning therapy to mitigate the donor and travel risks associated with the COVID-19 pandemic. However, little is known regarding...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Purtill, Duncan, Antonenas, Vicki, Chiappini, Paul, Tong, Daochen, O’Flaherty, Elizabeth, Bajel, Ashish, Kabani, Karieshma, Larsen, Stephen, Tan, Suikeat, Hutchins, Cheryl, Curtis, David J., Kennedy, Glen A., Watson, Anne-Marie, Bai, LiJun, Greenwood, Matthew, Gottlieb, David J., Hamad, Nada
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479963/
https://ncbi.nlm.nih.gov/pubmed/32886750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002431
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados